Cannabis abuse
ICD-10 F12.1 is a billable code used to indicate a diagnosis of cannabis abuse.
Cannabis abuse is characterized by a pattern of cannabis use leading to clinically significant impairment or distress. This includes recurrent use resulting in a failure to fulfill major role obligations at work, school, or home, and continued use despite persistent social or interpersonal problems caused or exacerbated by the effects of cannabis. Individuals may experience cravings, increased tolerance, and withdrawal symptoms when not using cannabis. The DSM-5 outlines specific criteria for diagnosing cannabis use disorder, which includes a range of behavioral, psychological, and physiological symptoms. Treatment often involves behavioral therapies, counseling, and support groups, with a focus on reducing use and addressing underlying issues. The prevalence of cannabis abuse has increased with changing legal statuses and societal attitudes towards cannabis, necessitating a comprehensive understanding of its impact on health and well-being.
Detailed history of substance use, treatment history, and psychosocial factors.
Patients presenting with withdrawal symptoms, cravings, or co-occurring mental health disorders.
Consideration of legal status of cannabis in the patient's location and its impact on treatment options.
Comprehensive mental health evaluation, including assessment of cannabis use and its effects on mental health.
Patients with anxiety, depression, or psychosis related to cannabis use.
Differentiating between primary psychiatric disorders and those exacerbated by cannabis use.
Used when counseling patients about cannabis cessation.
Document the counseling session details and patient responses.
Addiction specialists may need to provide more extensive documentation.
Cannabis abuse refers to the use of cannabis that leads to significant impairment or distress without the presence of physical dependence, while cannabis dependence includes criteria such as tolerance and withdrawal symptoms.
